NORTHERN TRUST CORP - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 40 filers reported holding INOZYME PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q3 2023$1,405,518
-16.0%
334,647
+11.4%
0.00%
Q2 2023$1,673,133
+536.4%
300,383
+554.7%
0.00%
Q1 2023$262,903
+445.0%
45,882
-0.1%
0.00%
Q4 2022$48,240
-55.3%
45,943
+14.0%
0.00%
Q3 2022$108,000
-51.8%
40,304
-14.2%
0.00%
Q2 2022$224,000
-51.9%
46,990
-58.7%
0.00%
Q1 2022$466,000
-43.4%
113,823
-5.7%
0.00%
Q4 2021$823,000
-38.8%
120,762
+4.0%
0.00%
Q3 2021$1,345,000
-34.6%
116,101
-3.8%
0.00%
Q2 2021$2,057,000
-10.0%
120,743
+4.6%
0.00%
Q1 2021$2,286,000
+19.4%
115,469
+24.4%
0.00%
Q4 2020$1,915,000
-21.5%
92,806
+0.0%
0.00%
-100.0%
Q3 2020$2,439,00092,7640.00%
Other shareholders
INOZYME PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,591,154$18,441,0006.52%
CHI Advisors LLC 920,264$10,666,0003.11%
Sofinnova Investments, Inc. 2,028,308$23,508,0001.39%
MPM BioImpact LLC 320,724$3,717,0000.58%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,344,786$27,176,0000.53%
NEA Management Company, LLC 2,444,379$28,330,0000.34%
Rock Springs Capital Management LP 850,015$9,852,0000.21%
SUVRETTA CAPITAL MANAGEMENT, LLC 986,400$11,432,0000.19%
Overbrook Management Corp 16,726$194,0000.04%
Orbimed Advisors 294,000$3,407,0000.04%
View complete list of INOZYME PHARMA INC shareholders